A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 38/20 (2006.01) A61K 39/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2343355
The use of professional antigen presenting cells genetically modified to enhance expression of an immunostimulatory cytokine is disclosed for the treatment of individuals having tumors or infections. The genetically modified professional antigen presenting cells are injected directly at or near the site of the tumor or infection. Preferred professional antigen presenting cells include dendritic cells, and preferred immunostimulatory cytokines include interleukins such as IL-12.
L'invention concerne l'utilisation de cellules professionnelles présentant un antigène qui sont génétiquement modifiées. Cette utilisation permet d'améliorer l'expression d'une cytokine immunostimulatrice et de traiter des sujets présentant des tumeurs ou des infections. Ces cellules professionnelles présentant un antigène génétiquement modifiées sont injectées directement sur le site de la tumeur ou de l'infection ou près de ce site. Parmi les cellules professionnelles présentant un antigène préférées figurent les cellules dendritiques et parmi les cytokines immunostimulatrices préférées figurent des interleukines telles que IL-12.
Lotze Michael T.
Nishioka Yasuhiko
Tahara Hideaki
Sim & Mcburney
University Of Pittsburgh Of The Commonwealth System Of Higher Ed
LandOfFree
In situ injection of antigen-presenting cells with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In situ injection of antigen-presenting cells with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In situ injection of antigen-presenting cells with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1421706